Aevi Genomic Medicine Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $23.5M

Aevi Genomic Medicine General Information

Description

Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine.

Contact Information

Formerly Known As
Biogenics, MedGenics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 435 Devon Park Drive
  • Suite 715
  • Wayne, PA 19087
  • United States
+1 (610) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aevi Genomic Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 03-Feb-2020 $23.5M 000.00 000.00 Completed Generating Revenue
11. PIPE 17-Oct-2017 0000 000.00 Completed Generating Revenue
10. 2PO 24-Jun-2016 0000 000.00 Completed Generating Revenue
9. PIPE 19-Jun-2012 00.00 000.00 Completed Generating Revenue
8. Debt - General 04-Nov-2010 000 0000 Completed Generating Revenue
7. PIPE 26-May-2010 00000 0000 Completed Generating Revenue
6. Debt - General 23-Jun-2009 00000 000.00 Completed Generating Revenue
5. IPO 04-Dec-2007 00.000 000.00 000.00 Completed Generating Revenue
4. Angel (individual) 19-Apr-2006 $27K $19.6M Completed Startup
3. Early Stage VC (Series B) 25-Apr-2003 $12.3M $19.5M 000.00 Completed Startup
To view Aevi Genomic Medicine’s complete valuation and funding history, request access »

Aevi Genomic Medicine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1 0,000,000 00.000000 00.00 00 00 00 00
Series B 0,000,000 00.000000 00.00 00 00 00 00 00.00
Series A1 4,224,339 $0.000100 $0.14 $1.71 $1.71 1x $1.71
Series A 4,224,339 $0.000100 $0.14 $1.71 $1.71 1x $1.71 26.99%
To view Aevi Genomic Medicine’s complete cap table history, request access »

Aevi Genomic Medicine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves t
Drug Discovery
Wayne, PA
14 As of 2018
000.00
000.00 0000-00-00
000000&0 000.00

0000 0

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
0000000000000
Santa Monica, CA
0000 As of 0000
00000
000.00 0000-00-00
000000&0 00000

000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid
0000000000000
Philadelphia, PA
0000
0000 0000-00-00
0000000000 0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aevi Genomic Medicine Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA 0000 00000 000000&0 00000
Limelight Bio Formerly VC-backed Philadelphia, PA 0000 0000000000 0 0000
New England Biolabs Corporation Ipswich, MA 000 0000000000
Caris Life Sciences Private Equity-Backed Irving, TX 0000 00.00 00000000000 00.00
Palvella Therapeutics Venture Capital-Backed Wayne, PA 00 00000 00000000000 00000
You’re viewing 5 of 28 competitors. Get the full list »

Aevi Genomic Medicine Executive Team (11)

Name Title Board Seat Contact Info
Marvin Garovoy MD Chief Medical Officer
You’re viewing 1 of 11 executive team members. Get the full list »

Aevi Genomic Medicine Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aevi Genomic Medicine Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alta Berkeley Venture Capital Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
Andrew Klopfer Angel (individual) Minority 000 0000 000000 0
CIBC Capital Markets Investment Bank Minority 000 0000 000000 0
Chicago Private Investments Other Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Aevi Genomic Medicine Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
neuroFix Therapeutics 09-Sep-2015 0000000000 00000 Drug Discovery 0000000 0
To view Aevi Genomic Medicine’s complete acquisitions history, request access »

Aevi Genomic Medicine FAQs

  • When was Aevi Genomic Medicine founded?

    Aevi Genomic Medicine was founded in 2000.

  • Where is Aevi Genomic Medicine headquartered?

    Aevi Genomic Medicine is headquartered in Wayne, PA.

  • What is the size of Aevi Genomic Medicine?

    Aevi Genomic Medicine has 14 total employees.

  • What industry is Aevi Genomic Medicine in?

    Aevi Genomic Medicine’s primary industry is Drug Discovery.

  • Is Aevi Genomic Medicine a private or public company?

    Aevi Genomic Medicine is a Private company.

  • What is the current valuation of Aevi Genomic Medicine?

    The current valuation of Aevi Genomic Medicine is 000.00.

  • What is Aevi Genomic Medicine’s current revenue?

    The current revenue for Aevi Genomic Medicine is 000000.

  • How much funding has Aevi Genomic Medicine raised over time?

    Aevi Genomic Medicine has raised $89.5M.

  • Who are Aevi Genomic Medicine’s investors?

    Alta Berkeley, Alta Partners, Andrew Klopfer, CIBC Capital Markets, and Chicago Private Investments are 5 of 12 investors who have invested in Aevi Genomic Medicine.

  • Who are Aevi Genomic Medicine’s competitors?

    Kite Pharma, Limelight Bio, New England Biolabs, Caris Life Sciences, and Palvella Therapeutics are some of the 28 competitors of Aevi Genomic Medicine.

  • When was Aevi Genomic Medicine acquired?

    Aevi Genomic Medicine was acquired on 03-Feb-2020.

  • Who acquired Aevi Genomic Medicine?

    Aevi Genomic Medicine was acquired by Avalo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »